Diabetes Partnering & Deal-Making
Diabetes Drug Discovery & Development
The 10th Diabetes Drug Discovery & Developmental Conference is part of GTCbio’s Diabetes Summit which encompasses the drug discovery and partnering aspects of diabetes in two separate consecutive conferences. Experts from industry and academia will discuss strategies to target Type 1 and Type 2 diabetes in presentations, and round-table discussions that highlight basic research novel therapeutic targets, translation to the clinic, and other relevant topics.
- Going Back to the Basics – Street Light Effect
- Novel Therapeutic Targets & Strategies
- Translation to The Clinic: What’s in the Pipeline
- Joint Plenary Session: Where do We Stand with Cell Therapy in Diabetes?
This conference is part of the Diabetes Summit taking place April 5-7, 2017 in Boston, MA which includes two back-to-back conferences:
April 5-6, 2017: 10th Diabetes Drug Discovery & Development Conference
April 6-7, 2017: 7th Diabetes Partnering & Deal-Making Conference
The 2017 Advisory Committee
|2017 Advisory Board Members|
|Robert Geho, Diasome Pharmaceuticals Inc|
|Zan Fleming, Kinexum|
|Alan Cherrington, Vanderbilt|
|Nirja Patel, ALPCO Diagnostics|
|Vivek Shenoy, Renovo|
Amber Kempf at 626-256-6405 x110 or amber.kempf [at] gtcbio.com
For more information on Media Relations, please contact:
Jennifer Chu at 626-256-6405 x105 or jennifer.chu [at] gtcbio.com
The 2018 sponsorship is currently in process.
Please come back and visit this page for updates.
BELOW ARE THE SPONSORS FROM 2017.